A pain relieving reimbursement program? Effects of a value-based reimbursement program on patient reported outcome measures
Abstract Background Value-based reimbursement programs have become increasingly common. However, little is known about the effect of such programs on patient reported outcomes. Thus, the aim of this study was to analyze the effect of introducing a value-based reimbursement program on patient reporte...
| Published in: | BMC Health Services Research |
|---|---|
| Main Authors: | Thérèse Eriksson, Hans Tropp, Ann-Britt Wiréhn, Lars-Åke Levin |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-08-01
|
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12913-020-05578-8 |
Similar Items
A cost-reducing reimbursement programme? Effects of value-based reimbursement on healthcare costs
by: Thérèse Eriksson, et al.
Published: (2024-12-01)
by: Thérèse Eriksson, et al.
Published: (2024-12-01)
Impact of reimbursement systems on patient care – a systematic review of systematic reviews
by: Eva Wagenschieber, et al.
Published: (2024-03-01)
by: Eva Wagenschieber, et al.
Published: (2024-03-01)
Strategies for spinal surgery reimbursement: bundling in the working-age population
by: Michael K. Dalton, et al.
Published: (2021-02-01)
by: Michael K. Dalton, et al.
Published: (2021-02-01)
Analysis of oral hypoglycemic drugs that are subject to reimbursement in Ukraine
by: I. O. Vlasenko
Published: (2022-10-01)
by: I. O. Vlasenko
Published: (2022-10-01)
Financial incentives for generic drugs: case study on a reimbursement program
by: Marcos Inocencio, et al.
Published: (2010-06-01)
by: Marcos Inocencio, et al.
Published: (2010-06-01)
Variation in expenditure for common, high cost surgical procedures in a working age population: implications for reimbursement reform
by: W. Wynn-Jones, et al.
Published: (2019-11-01)
by: W. Wynn-Jones, et al.
Published: (2019-11-01)
Medical oncologists’ willingness to participate in bundled payment programs
by: Yonina R. Murciano-Goroff, et al.
Published: (2018-05-01)
by: Yonina R. Murciano-Goroff, et al.
Published: (2018-05-01)
Examining the association between oncology drug clinical benefit and the time to public reimbursement
by: Sasha Thomson, et al.
Published: (2022-01-01)
by: Sasha Thomson, et al.
Published: (2022-01-01)
Getting Ours? “Girlbossing” and the Ethics of Nurse Reimbursement Models
by: Danisha Jenkins, et al.
Published: (2024-12-01)
by: Danisha Jenkins, et al.
Published: (2024-12-01)
Equivalent Modes of Reimbursement in Augmented Contests
by: Chen Cohen, et al.
Published: (2023-03-01)
by: Chen Cohen, et al.
Published: (2023-03-01)
The Impact of the Clinical Miscoding on Inpatient Reimbursement
by: Roghayeh Ershad Sarabi, et al.
Published: (2020-03-01)
by: Roghayeh Ershad Sarabi, et al.
Published: (2020-03-01)
Factors Influencing the Introduction of Value-Based Payment in Integrated Stroke Care: 'Evidence from a Qualitative Case Study'
by: Newel Salet, et al.
Published: (2023-08-01)
by: Newel Salet, et al.
Published: (2023-08-01)
Stratified Medicine and Reimbursement Issues
by: Hans-Joerg eFugel, et al.
Published: (2012-10-01)
by: Hans-Joerg eFugel, et al.
Published: (2012-10-01)
Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01)
by: Bérengère Macabeo, et al.
Published: (2023-12-01)
Reimbursement of care does not equal the distribution of hospital resources: an explorative case study on a missing link among Dutch hospitals
by: L. V. L. van Leeuwen, et al.
Published: (2023-09-01)
by: L. V. L. van Leeuwen, et al.
Published: (2023-09-01)
Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews
by: Thomas Desmet, et al.
Published: (2025-01-01)
by: Thomas Desmet, et al.
Published: (2025-01-01)
Utilization of second medical opinions as a function of the payment method
by: Liora Shmueli, et al.
Published: (2025-02-01)
by: Liora Shmueli, et al.
Published: (2025-02-01)
Recent advances in addressing the market failure of new antimicrobials: Learnings from NICE's subscription-style payment model
by: Marieke Schurer, et al.
Published: (2023-02-01)
by: Marieke Schurer, et al.
Published: (2023-02-01)
New reimbursement model in Icelandic primary care in 2017: first-year comparison of public and private primary care
by: Hedinn Sigurdsson, et al.
Published: (2022-04-01)
by: Hedinn Sigurdsson, et al.
Published: (2022-04-01)
How to Pay for Telemedicine: A Comparison of Ten Health Systems
by: Sarah Raes, et al.
Published: (2022-01-01)
by: Sarah Raes, et al.
Published: (2022-01-01)
Medicare Reimbursement Trends in Zenker's Diverticulectomy
by: George S. Bebawy, et al.
Published: (2025-10-01)
by: George S. Bebawy, et al.
Published: (2025-10-01)
THE AUDIT OF EU NON-REIMBURSABLE FUNDS
by: OCOLIȘANU ANDREEA
Published: (2019-10-01)
by: OCOLIȘANU ANDREEA
Published: (2019-10-01)
What is the role of antineoplastic drug safety in reimbursement decision making?
by: A. S. Kolbin, et al.
Published: (2018-11-01)
by: A. S. Kolbin, et al.
Published: (2018-11-01)
Reimbursement measures in European countries – findings of a bibliometric literature review
by: Sabine Vogler, et al.
Published: (2015-12-01)
by: Sabine Vogler, et al.
Published: (2015-12-01)
The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer
by: Sarah Sharman Moser, et al.
Published: (2023-02-01)
by: Sarah Sharman Moser, et al.
Published: (2023-02-01)
The History of Reimbursements in Neurology
by: Shaheen E Lakhan, et al.
Published: (2013-11-01)
by: Shaheen E Lakhan, et al.
Published: (2013-11-01)
The Effect of Network-Level Payment Models on Care Network Performance: A Scoping Review of the Empirical Literature
by: Thomas Reindersma, et al.
Published: (2022-04-01)
by: Thomas Reindersma, et al.
Published: (2022-04-01)
THEORETICAL AND PRACTICAL ASPECTS REGARDING THE ADJUSTMENT AND REIMBURSEMENT OF VALUE ADDED TAX
by: CIUMAG MARIN, et al.
Published: (2021-10-01)
by: CIUMAG MARIN, et al.
Published: (2021-10-01)
Take the Money and Run: The Challenges of Designing and Evaluating Financial Incentives in Healthcare; Comment on “Paying for Performance in Healthcare Organisations”
by: Russell Mannion
Published: (2014-02-01)
by: Russell Mannion
Published: (2014-02-01)
Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries
by: Juan Carlos Rejon-Parrilla, et al.
Published: (2023-11-01)
by: Juan Carlos Rejon-Parrilla, et al.
Published: (2023-11-01)
The new remuneration system TARPSY in Swiss psychiatric hospitals: effects on length of stay and readmissions?
by: Urs Hepp, et al.
Published: (2020-09-01)
by: Urs Hepp, et al.
Published: (2020-09-01)
Challenges of Payment Methods in the Iranian Health System and Solutions: A Qualitative Study
by: Mohsen Barouni, et al.
Published: (2020-06-01)
by: Mohsen Barouni, et al.
Published: (2020-06-01)
Total inpatient treatment costs in patients with severe burns: towards a more accurate reimbursement model
by: Tarun Mehra, et al.
Published: (2015-11-01)
by: Tarun Mehra, et al.
Published: (2015-11-01)
Workshop integrating care by payment reform; the case of Dutch birth care
by: Jeroen Struijs, et al.
Published: (2019-08-01)
by: Jeroen Struijs, et al.
Published: (2019-08-01)
THE PROCEDURE OF REIMBURSEMENT OF THE COSTS INCURRED IN A TRIAL, IN A SUBSEQUENT TRIAL
by: Georgiana COMAN
Published: (2022-06-01)
by: Georgiana COMAN
Published: (2022-06-01)
Drug pricing and reimbursement decision making systems in Mongolia
by: Gereltuya Dorj, et al.
Published: (2017-12-01)
by: Gereltuya Dorj, et al.
Published: (2017-12-01)
Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria
by: Georgi Iskrov, et al.
Published: (2016-02-01)
by: Georgi Iskrov, et al.
Published: (2016-02-01)
Reimbursement Models in Healthcare: Diagnosis Related Groups and Case Mix
by: Okan Özkan, et al.
Published: (2016-04-01)
by: Okan Özkan, et al.
Published: (2016-04-01)
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017-01-01)
by: Karolina Badora, et al.
Published: (2017-01-01)
Health technology assessment and reimbursement of pharmaceuticals in Italy
by: F. V. Gorkavenko, et al.
Published: (2019-07-01)
by: F. V. Gorkavenko, et al.
Published: (2019-07-01)
Similar Items
-
A cost-reducing reimbursement programme? Effects of value-based reimbursement on healthcare costs
by: Thérèse Eriksson, et al.
Published: (2024-12-01) -
Impact of reimbursement systems on patient care – a systematic review of systematic reviews
by: Eva Wagenschieber, et al.
Published: (2024-03-01) -
Strategies for spinal surgery reimbursement: bundling in the working-age population
by: Michael K. Dalton, et al.
Published: (2021-02-01) -
Analysis of oral hypoglycemic drugs that are subject to reimbursement in Ukraine
by: I. O. Vlasenko
Published: (2022-10-01) -
Financial incentives for generic drugs: case study on a reimbursement program
by: Marcos Inocencio, et al.
Published: (2010-06-01)
